{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:15:21Z","timestamp":1777972521052,"version":"3.51.4"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00251-022-01261-w","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T07:15:50Z","timestamp":1648538150000},"page":"381-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6483-8660","authenticated-orcid":false,"given":"Susana","family":"David","sequence":"first","affiliation":[]},{"given":"Guillermo","family":"Dorado","sequence":"additional","affiliation":[]},{"given":"Elsa L.","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Stephanie","family":"David-Bosne","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Trigueiro-Louro","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Rebelo-de-Andrade","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"issue":"4","key":"1261_CR1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124(4):783\u2013801","journal-title":"Cell"},{"key":"1261_CR2","doi-asserted-by":"crossref","unstructured":"Alangari AA, Al-Zamil F, Al-Mazrou A et al (2011) Treatment of disseminated mycobacterial infection with high-dose IFN-\u03b3 in a patient with IL-12R\u03b21 deficiency. Clin Dev Immunol 2011:691956.","DOI":"10.1155\/2011\/691956"},{"key":"1261_CR3","doi-asserted-by":"crossref","unstructured":"Amati F, Vancheri C, Latini A, Colona VL, Grelli S, D'Apice MR et al (2020) Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients. Heliyon 6(10):e05143","DOI":"10.1016\/j.heliyon.2020.e05143"},{"issue":"1","key":"1261_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40246-020-00290-4","volume":"14","author":"C Anastassopoulou","year":"2020","unstructured":"Anastassopoulou C, Gkizarioti Z, Patrinos GP, Tsakris A (2020) Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum Genomics 14(1):1\u20138","journal-title":"Hum Genomics"},{"key":"1261_CR5","doi-asserted-by":"publisher","unstructured":"Ansari MA, Marchi E, Ramamurthy N et al (2020) Negative regulation of ACE2 by interferons in vivo and its genetic control medRxiv.\u00a0https:\/\/doi.org\/10.1101\/2020.04.26.20080408","DOI":"10.1101\/2020.04.26.20080408"},{"issue":"11","key":"1261_CR6","doi-asserted-by":"publisher","first-page":"10087","DOI":"10.18632\/aging.103415","volume":"12","author":"R Asselta","year":"2020","unstructured":"Asselta R, Paraboschi EM, Mantovani A, Duga S (2020) ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (albany NY) 12(11):10087","journal-title":"Aging (albany NY)"},{"issue":"5","key":"1261_CR7","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1002\/jmv.26853","volume":"93","author":"K Aykac","year":"2021","unstructured":"Aykac K, Cura Yayla BC, Ozsurekci Y et al (2021) The association of viral load and disease severity in children with COVID-19. J Med Virol 93(5):3077\u20133083","journal-title":"J Med Virol"},{"issue":"14","key":"1261_CR8","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2020.2565","volume":"323","author":"Y Bai","year":"2020","unstructured":"Bai Y, Yao L, Wei T et al (2020) Presumed asymptomatic carrier transmission of COVID-19. JAMA 323(14):1406\u20131407","journal-title":"JAMA"},{"key":"1261_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1126\/science.1255074","volume":"344","author":"JK Baillie","year":"2014","unstructured":"Baillie JK (2014) Targeting the host immune response to fight infection. Science 344:807\u2013808","journal-title":"Science"},{"key":"1261_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41588-021-00805-2","volume":"53","author":"J Baggen","year":"2021","unstructured":"Baggen J, Persoons L, Vanstreels E et al (2021) Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2. Nat Genet 53:435\u2013444","journal-title":"Nat Genet"},{"key":"1261_CR11","doi-asserted-by":"crossref","unstructured":"Bakhshandeh B, Jahanafrooz Z, Abbasi A et al (2021) Mutations in SARS-CoV-2; Consequences in structure function and pathogenicity of the virus. Microb Pathog 154:104831","DOI":"10.1016\/j.micpath.2021.104831"},{"issue":"1","key":"1261_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-03621-1","volume":"9","author":"AN Barbeira","year":"2018","unstructured":"Barbeira AN, Dickinson SP, Bonazzola R et al (2018) Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat Commun 9(1):1\u201320","journal-title":"Nat Commun"},{"key":"1261_CR13","doi-asserted-by":"crossref","unstructured":"Barreiro LB, Ben-Ali M, Quach H et al (2009) Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet 5(7):e1000562","DOI":"10.1371\/journal.pgen.1000562"},{"key":"1261_CR14","doi-asserted-by":"crossref","unstructured":"Bastard P, Rosen LB, Zhang Q et al (2020) Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370(6515):eabd4585","DOI":"10.1126\/science.abd4585"},{"issue":"6","key":"1261_CR15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/v4061011","volume":"4","author":"S Belouzard","year":"2012","unstructured":"Belouzard S, Millet JK, Licitra BN, Whittaker GR (2012) Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 4(6):1011\u20131033","journal-title":"Viruses"},{"issue":"11","key":"1261_CR16","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41431-020-0691-z","volume":"28","author":"E Benetti","year":"2020","unstructured":"Benetti E, Tita R, Spiga O et al (2020) ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population. Eur J Hum Genet 28(11):1602\u20131614","journal-title":"Eur J Hum Genet"},{"key":"1261_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.03.024257","author":"D Bojkova","year":"2020","unstructured":"Bojkova D, McGreig JE et al (2020) SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles. BioRxiv. https:\/\/doi.org\/10.1101\/2020.04.03.024257","journal-title":"BioRxiv"},{"issue":"1","key":"1261_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/ije\/dyaa229","volume":"50","author":"G Butler-Laporte","year":"2021","unstructured":"Butler-Laporte G, Nakanishi T, Mooser V et al (2021) The effect of angiotensin-converting enzyme levels on Covid-19 susceptibility and severity: a Mendelian randomization study. Int J Epidemiol 50(1):75\u201386","journal-title":"Int J Epidemiol"},{"issue":"9","key":"1261_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.15585\/mmwr.mm6909e1","volume":"69","author":"RM Burke","year":"2020","unstructured":"Burke RM, Midgley CM, Dratch A et al (2020) Active monitoring of persons exposed to patients with confirmed COVID-19\u2014United States, January\u2013February 2020. Morb Mortal Wkly Rep 69(9):245","journal-title":"Morb Mortal Wkly Rep"},{"issue":"1","key":"1261_CR20","first-page":"1","volume":"6","author":"Y Cao","year":"2020","unstructured":"Cao Y, Li L, Feng Z et al (2020) Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations. Cell Disc 6(1):1\u20134","journal-title":"Cell Disc"},{"key":"1261_CR21","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3389\/fimmu.2020.01606","volume":"11","author":"ME Carter-Timofte","year":"2020","unstructured":"Carter-Timofte ME, J\u00f8rgensen SE, Freytag MR et al (2020) Deciphering the role of host genetics in susceptibility to severe COVID-19. Front Immunol 11:1606","journal-title":"Front Immunol"},{"issue":"11","key":"1261_CR22","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1084\/jem.20140520","volume":"211","author":"JL Casanova","year":"2014","unstructured":"Casanova JL, Conley ME, Seligman SJ et al (2014) Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J Exp Med 211(11):2137\u20132149","journal-title":"J Exp Med"},{"key":"1261_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00439-020-02184-w","volume":"139","author":"JL Casanova","year":"2020","unstructured":"Casanova JL, Abel L (2020) The human genetic determinism of life-threatening infectious diseases: genetic heterogeneity and physiological homogeneity? Hum Genet 139:681\u2013694","journal-title":"Hum Genet"},{"issue":"6","key":"1261_CR24","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2020.05.016","volume":"181","author":"JL Casanova","year":"2020","unstructured":"Casanova JL, Su HC, Abel L et al (2020) A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection. Cell 181(6):1194\u20131199","journal-title":"Cell"},{"key":"1261_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-pathol-031920-101429","volume":"16","author":"JL Casanova","year":"2021","unstructured":"Casanova JL, Abel L (2021) Lethal infectious diseases as inborn errors of immunity: toward a synthesis of the germ and genetic theories. Ann Rev Pathol 16:23\u201350","journal-title":"Ann Rev Pathol"},{"key":"1261_CR26","unstructured":"Centers for Disease Control and Prevention, CDC (2021). SARS-CoV-2 variant classifications and definitions. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/variants\/variant-info.html#Interest. Accessed 19 Nov\u00a02021"},{"issue":"6233","key":"1261_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1126\/science.aaa1578","volume":"348","author":"MJ Ciancanelli","year":"2015","unstructured":"Ciancanelli MJ, Huang SX, Luthra P et al (2015) Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 348(6233):448\u2013453","journal-title":"Science"},{"issue":"12","key":"1261_CR28","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.1128\/JVI.00009-13","volume":"87","author":"RW Chan","year":"2013","unstructured":"Chan RW, Chan MC, Agnihothram S et al (2013) Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol 87(12):6604\u20136614","journal-title":"J Virol"},{"key":"1261_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.00102-14","volume":"28","author":"JF Chan","year":"2015","unstructured":"Chan JF, Lau SK, To KK, Cheng VC et al (2015) Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 28:465\u2013522","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"1261_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"R Channappanavar","year":"2017","unstructured":"Channappanavar R, Perlman S (2017) Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 39(5):529\u2013539","journal-title":"Semin Immunopathol"},{"key":"1261_CR31","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1172\/JCI126363","volume":"129","author":"R Channappanavar","year":"2019","unstructured":"Channappanavar R, Fehr AR, Zheng J et al (2019) IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest 129:3625\u20133639","journal-title":"J Clin Invest"},{"issue":"10","key":"1261_CR32","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1093\/cid\/ciaa711","volume":"71","author":"NVV Chau","year":"2020","unstructured":"Chau NVV, Thanh Lam V, Thanh Dung N et al (2020) The natural history and transmission potential of asymptomatic SARS-CoV-2 infection. Clin Infect Dis 71(10):2679\u20132687","journal-title":"Clin Infect Dis"},{"key":"1261_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fimmu.2018.00320","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Liu S, Goraya MU et al (2018) Host immune response to influenza A virus infection. Front Immunol 9:320","journal-title":"Front Immunol"},{"issue":"4","key":"1261_CR34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92(4):418\u2013423","journal-title":"J Med Virol"},{"issue":"8","key":"1261_CR35","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1093\/infdis\/jiv246","volume":"212","author":"Z Cheng","year":"2015","unstructured":"Cheng Z, Zhou J, To KKW et al (2015) Identification of TMPRSS2 as a susceptibility gene for severe 2009 pandemic A (H1N1) influenza and A (H7N9) influenza. J Infect Dis 212(8):1214\u20131221","journal-title":"J Infect Dis"},{"key":"1261_CR36","doi-asserted-by":"crossref","unstructured":"Cilloni L, Fu H, Vesga JF et al (2020) The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. E Clin Med 28:100603","DOI":"10.1016\/j.eclinm.2020.100603"},{"issue":"8","key":"1261_CR37","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/s41563-020-0698-4","volume":"19","author":"NJ Cho","year":"2020","unstructured":"Cho NJ, Glenn JS (2020) Materials science approaches in the development of broad-spectrum antiviral therapies. Nat Mater 19(8):813\u2013816","journal-title":"Nat Mater"},{"key":"1261_CR38","doi-asserted-by":"crossref","unstructured":"Chou J, Thomas PG, Randolph AG (2022) Immunology of SARS-CoV-2 infection in children. Nat Immunol 1\u20139","DOI":"10.1038\/s41590-021-01123-9"},{"issue":"6","key":"1261_CR39","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/infdis\/jiv380","volume":"213","author":"H Chu","year":"2016","unstructured":"Chu H, Zhou J, Wong BHY et al (2016) Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis 213(6):904\u2013914","journal-title":"J Infect Dis"},{"issue":"2","key":"1261_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10495-006-3486-y","volume":"11","author":"CE Chwieralski","year":"2006","unstructured":"Chwieralski CE, Welte T, B\u00fchling F (2006) Cathepsin-regulated apoptosis. Apoptosis 11(2):143\u2013149","journal-title":"Apoptosis"},{"key":"1261_CR41","doi-asserted-by":"crossref","unstructured":"Coutard B, Valle C, de Lamballerie X et al (2020) The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir Res 176:104742","DOI":"10.1016\/j.antiviral.2020.104742"},{"issue":"1","key":"1261_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-020-00297-x","volume":"15","author":"VL Colona","year":"2021","unstructured":"Colona VL, Vasiliou V, Watt J, Novelli G, Reichardt JK (2021a) Update on human genetic susceptibility to COVID-19: susceptibility to virus and response. Hum Genomics 15(1):1\u20138","journal-title":"Hum Genomics"},{"key":"1261_CR43","doi-asserted-by":"crossref","unstructured":"Colona VL, Biancolella M, Novelli A, Novelli G (2021b) Will GWAS eventually allow the identification of genomic biomarkers for COVID-19 severity and mortality? J Clin Invest 131(23)","DOI":"10.1172\/JCI155011"},{"key":"1261_CR44","doi-asserted-by":"publisher","unstructured":"COVID-19 Host Genetics Initiative (2021) Mapping the human genetic architecture of COVID-19 by worldwide meta-analysis MedRxiv.\u00a0https:\/\/doi.org\/10.1101\/2021.03.10.21252820","DOI":"10.1101\/2021.03.10.21252820"},{"key":"1261_CR45","doi-asserted-by":"crossref","unstructured":"COVID-19 Host Genetics Initiative (2020) The COVID-19 host genetics initiative a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Hum Genet 28(6):715","DOI":"10.1038\/s41431-020-0636-6"},{"issue":"3","key":"1261_CR46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jinf.2020.10.017","volume":"82","author":"E Dahdouh","year":"2021","unstructured":"Dahdouh E, L\u00e1zaro-Perona F, Romero-G\u00f3mez MP et al (2021) Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load. J Infect 82(3):414\u2013451","journal-title":"J Infect"},{"issue":"12","key":"1261_CR47","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nri1732","volume":"5","author":"AA Dandekar","year":"2005","unstructured":"Dandekar AA, Perlman S (2005) Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol 5(12):917\u2013927","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1261_CR48","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cell.2020.10.030","volume":"184","author":"Z Daniloski","year":"2021","unstructured":"Daniloski Z, Jordan TX, Wessels HH et al (2021) Identification of required host factors for SARS-CoV-2 infection in human cells. Cell 184(1):92\u2013105","journal-title":"Cell"},{"issue":"12","key":"1261_CR49","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.tig.2021.07.009","volume":"37","author":"S David","year":"2021","unstructured":"David S (2021) A current guide to candidate gene association studies. Trends Genet 37(12):1056\u20131059","journal-title":"Trends Genet"},{"key":"1261_CR50","doi-asserted-by":"crossref","unstructured":"David A, Parkinson N, Peacock TP, Pairo-Castineira E, Khanna T, Cobat A et al (2022) A common TMPRSS2 variant has a protective effect against severe COVID-19. Current research in translational medicine 70(2):103333","DOI":"10.1016\/j.retram.2022.103333"},{"key":"1261_CR51","unstructured":"Davies NG, Abbott S, Barnard RC et al (2020) Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012\/01 in England. Science 372(6538)"},{"issue":"7","key":"1261_CR52","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.1096\/fj.202001115R","volume":"34","author":"M Debnath","year":"2020","unstructured":"Debnath M, Banerjee M, Berk M (2020) Genetic gateways to COVID-19 infection: Implications for risk severity and outcomes. FASEB J 34(7):8787\u20138795","journal-title":"FASEB J"},{"issue":"1","key":"1261_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddiscovery.2016.12","volume":"2","author":"MAG De Castro","year":"2016","unstructured":"De Castro MAG, Bunt G, Wouters FS (2016) Cathepsin B launches an apoptotic exit effort upon cell death-associated disruption of lysosomes. Cell Death Discov 2(1):1\u20138","journal-title":"Cell Death Discov"},{"key":"1261_CR54","first-page":"1","volume":"419","author":"AH De Wilde","year":"2018","unstructured":"De Wilde AH, Snijder EJ, Kikkert M, van Hemert MJ (2018) Host factors in coronavirus replication. Curr Top Microbiol Immunol 419:1\u201342","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"1261_CR55","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jmii.2020.04.015","volume":"53","author":"CA Devaux","year":"2020","unstructured":"Devaux CA, Rolain JM, Raoult D (2020) ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2 hypertension multi-organ failure and COVID-19 disease outcome. J Microbiol Immunol Infect 53(3):425\u2013435","journal-title":"J Microbiol Immunol Infect"},{"key":"1261_CR56","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao B, Wang C, Tan Y et al (2020) Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 11:827","journal-title":"Front Immunol"},{"issue":"5","key":"1261_CR57","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong E, Du H, Gardner L (2020) An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 20(5):533\u2013534","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"1261_CR58","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3201\/eid2509.190143","volume":"25","author":"CA Donnelly","year":"2019","unstructured":"Donnelly CA, Malik MR, Elkholy A et al (2019) Worldwide reduction in MERS cases and deaths since 2016. Emerg Infect Dis 25(9):1758","journal-title":"Emerg Infect Dis"},{"key":"1261_CR59","doi-asserted-by":"crossref","unstructured":"Duarte CM, Jamil T, Gojobori T, Alam I (2021) Detection of SARS-CoV-2 variants requires urgent global coordination Int J Infect Dis 109:50\u201353","DOI":"10.1016\/j.ijid.2021.06.027"},{"key":"1261_CR60","doi-asserted-by":"crossref","unstructured":"Escobedo A, Kaushal D, Singh K (2022) Insights into the changing landscape of coronavirus disease 2019. Front Cell Infect Microbiol 11","DOI":"10.3389\/fcimb.2021.761521"},{"key":"1261_CR61","unstructured":"European Centre for Disease Prevention and Control, ECDC (2020) Detection of new SARS-CoV-2 variants related to mink. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/RRA-SARS-CoV-2-in-mink-12-nov-2020.pdf"},{"key":"1261_CR62","doi-asserted-by":"crossref","unstructured":"Elhabyan A, El Yaacoub S, Sanad et al (2020) The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review. Virus Res 289:198163","DOI":"10.1016\/j.virusres.2020.198163"},{"issue":"16","key":"1261_CR63","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","volume":"383","author":"D Ellinghaus","year":"2020","unstructured":"Ellinghaus D, Degenhardt F, Bujanda L et al (2020) Severe Covid-19 GWAS Group Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med 383(16):1522\u20131534","journal-title":"N Engl J Med"},{"key":"1261_CR64","unstructured":"European Centers for Disease Control and Prevention, ECDC (2022) SARS-CoV-2 variants of concern as of 17 February 2022. https:\/\/www.ecdc.europa.eu\/en\/covid-19\/variants-concern.\u00a0Accessed 26\u00a0Feb\u00a02022"},{"issue":"1","key":"1261_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-19057-5","volume":"11","author":"J Fajnzylber","year":"2020","unstructured":"Fajnzylber J, Regan J, Coxen K et al (2020) SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun 11(1):1\u20139","journal-title":"Nat Commun"},{"issue":"2","key":"1261_CR66","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41418-020-00720-9","volume":"28","author":"G Forni","year":"2021","unstructured":"Forni G, Mantovani A (2021) COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ 28(2):626\u2013639","journal-title":"Cell Death Differ"},{"key":"1261_CR67","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3389\/fimmu.2020.02147","volume":"11","author":"N Gadi","year":"2020","unstructured":"Gadi N, Wu SC, Spihlman AP, Moulton VR (2020) What\u2019s sex got to do with COVID-19? Gender-based differences in the host immune response to coronaviruses. Front Immunol 11:2147","journal-title":"Front Immunol"},{"issue":"15","key":"1261_CR68","doi-asserted-by":"publisher","first-page":"446","DOI":"10.15585\/mmwr.mm6915e1","volume":"69","author":"I Ghinai","year":"2020","unstructured":"Ghinai I, Woods S, Ritger KA et al (2020) Community transmission of SARS-CoV-2 at two family gatherings\u2014Chicago, Illinois, February\u2013March 2020. Morb Mortal Wkly Rep 69(15):446","journal-title":"Morb Mortal Wkly Rep"},{"key":"1261_CR69","doi-asserted-by":"crossref","unstructured":"Golinelli D, Boetto E, Maietti E, Fantini MP (2020) The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis. PLoS One 15(9):e0239508","DOI":"10.1371\/journal.pone.0239508"},{"key":"1261_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40246-020-00267-3","volume":"14","author":"KJ Godri Pollitt","year":"2020","unstructured":"Godri Pollitt KJ, Peccia J, Ko AI et al (2020) COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission. Hum Genomics 14:1\u20137","journal-title":"Hum Genomics"},{"key":"1261_CR71","doi-asserted-by":"crossref","unstructured":"G\u00f3mez J, Albaiceta GM, Cuesta-Llavona E, Garc\u00eda-Clemente M, L\u00f3pez-Larrea C, Amado-Rodr\u00edguez L et al (2021) The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19. Cytokine 137:155354","DOI":"10.1016\/j.cyto.2020.155354"},{"issue":"4","key":"1261_CR72","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/nu12040988","volume":"12","author":"WB Grant","year":"2020","unstructured":"Grant WB, Lahore H, McDonnell SL et al (2020) Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12(4):988","journal-title":"Nutrients"},{"issue":"6504","key":"1261_CR73","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Yatim N, Barnabei L et al (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369(6504):718\u2013724","journal-title":"Science"},{"key":"1261_CR74","doi-asserted-by":"crossref","unstructured":"Hakonarson H, Gulcher JR, Stefansson K (2003) deCODE genetics Inc. Pharmacogenomics 4(2):209\u2013215","DOI":"10.1517\/phgs.4.2.209.22627"},{"key":"1261_CR75","doi-asserted-by":"crossref","unstructured":"Hamner L (2020) High SARS-CoV-2 attack rate following exposure at a choir practice-Skagit County, Washington, March 2020. MMWR Morbidity and mortality weekly report 69","DOI":"10.15585\/mmwr.mm6919e6"},{"issue":"1","key":"1261_CR76","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s15010-020-01548-8","volume":"49","author":"I Hasanoglu","year":"2021","unstructured":"Hasanoglu I, Korukluoglu G, Asilturk D et al (2021) Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg. Infection 49(1):117\u2013126","journal-title":"Infection"},{"key":"1261_CR77","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/mco2.110","volume":"2","author":"X He","year":"2021","unstructured":"He X, Hong W, Pan X et al (2021) SARS-CoV-2 Omicron variant: characteristics and prevention. MedComm 2:838\u2013845","journal-title":"MedComm"},{"key":"1261_CR78","doi-asserted-by":"crossref","unstructured":"He R, Lu Z, Zhang L et al (2020) The clinical course and its correlated immune status in COVID-19 pneumonia. J Clin Virol 127:104361","DOI":"10.1016\/j.jcv.2020.104361"},{"issue":"2","key":"1261_CR79","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/imm.12195","volume":"141","author":"SJ Hebbring","year":"2014","unstructured":"Hebbring SJ (2014) The challenges, advantages and future of phenome-wide association studies. Immunology 141(2):157\u2013165","journal-title":"Immunology"},{"issue":"4","key":"1261_CR80","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/v4040557","volume":"4","author":"T Heald-Sargent","year":"2012","unstructured":"Heald-Sargent T, Gallagher T (2012) Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses 4(4):557\u2013580","journal-title":"Viruses"},{"issue":"1","key":"1261_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-54849-w","volume":"9","author":"AD Hingorani","year":"2019","unstructured":"Hingorani AD, Kuan V, Finan C et al (2019) Improving the odds of drug development success through human genomics: modelling study. Sci Rep 9(1):1\u201325","journal-title":"Sci Rep"},{"issue":"13","key":"1261_CR82","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1056\/NEJMc2001899","volume":"382","author":"S Hoehl","year":"2020","unstructured":"Hoehl S, Rabenau H, Berger A et al (2020) Evidence of SARS-CoV-2 infection in returning travelers from Wuhan. China N Engl J Med 382(13):1278\u20131280","journal-title":"China N Engl J Med"},{"issue":"22","key":"1261_CR83","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.1073\/pnas.0409465102","volume":"102","author":"H Hofmann","year":"2005","unstructured":"Hofmann H, Pyrc K, Van Der Hoek L et al (2005) Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A 102(22):7988\u20137993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1261_CR84","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271\u2013280","journal-title":"Cell"},{"issue":"1","key":"1261_CR85","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/srin.2001.22728","volume":"16","author":"SM Holland","year":"2001","unstructured":"Holland SM (2001) Immunotherapy of mycobacterial infections. Semin Respir Infect 16(1):47\u201359","journal-title":"Semin Respir Infect"},{"issue":"9","key":"1261_CR86","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/jmv.25832","volume":"92","author":"M Hussain","year":"2020","unstructured":"Hussain M, Jabeen N, Raza F et al (2020) Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. J Med Virol 92(9):1580\u20131586","journal-title":"J Med Virol"},{"issue":"10223","key":"1261_CR87","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet 395(10223):497\u2013506","journal-title":"China Lancet"},{"issue":"7","key":"1261_CR88","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-2600(20)30193-4","volume":"8","author":"KP Hui","year":"2020","unstructured":"Hui KP, Cheung MC, Perera RA et al (2020) Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Resp Med 8(7):687\u2013695","journal-title":"Lancet Resp Med"},{"issue":"9","key":"1261_CR89","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1016\/S2352-3018(20)30211-3","volume":"7","author":"BL Jewell","year":"2020","unstructured":"Jewell BL, Mudimu E, Stover J et al (2020) Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models. Lancet HIV 7(9):e629\u2013e640","journal-title":"Lancet HIV"},{"issue":"11","key":"1261_CR90","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1016\/S1473-3099(20)30651-4","volume":"20","author":"L Jiang","year":"2020","unstructured":"Jiang L, Tang K, Levin M et al (2020) COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis 20(11):e276\u2013e288","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1261_CR91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27\u201330","journal-title":"Nucleic Acids Res"},{"issue":"10317","key":"1261_CR92","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","volume":"398","author":"SSA Karim","year":"2021","unstructured":"Karim SSA, Karim QA (2021) Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet 398(10317):2126\u20132128","journal-title":"Lancet"},{"issue":"1","key":"1261_CR93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2005.04.010","volume":"23","author":"H Kato","year":"2005","unstructured":"Kato H, Sato S, Yoneyama M et al (2005) Cell type-specific involvement of RIG-I in antiviral response. Immunity 23(1):19\u201328","journal-title":"Immunity"},{"key":"1261_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1443.020","volume":"1143","author":"T Kawai","year":"2008","unstructured":"Kawai T, Akira S (2008) Toll-like receptor and RIG-1-like receptor signaling. Ann N Y Acad Sci 1143:1\u201320","journal-title":"Ann N Y Acad Sci"},{"key":"1261_CR95","doi-asserted-by":"crossref","unstructured":"King EA, Davis JW, Degner JF (2019) Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet 15(12):e1008489","DOI":"10.1371\/journal.pgen.1008489"},{"issue":"1","key":"1261_CR96","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrmicro1326","volume":"4","author":"M Kielian","year":"2006","unstructured":"Kielian M, Rey FA (2006) Virus membrane-fusion proteins: more than one way to make a hairpin. Nature Rev Microbiol 4(1):67\u201376","journal-title":"Nature Rev Microbiol"},{"issue":"1","key":"1261_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-021-03662-x","volume":"25","author":"J Khateeb","year":"2021","unstructured":"Khateeb J, Li Y, Zhang H (2021) Emerging SARS-CoV-2 variants of concern and potential intervention approaches. Crit Care 25(1):1\u20138","journal-title":"Crit Care"},{"key":"1261_CR98","doi-asserted-by":"crossref","unstructured":"Koh WC, Naing L, Chaw L et al (2020) What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors. PloS one 15(10):e0240205","DOI":"10.1371\/journal.pone.0240205"},{"key":"1261_CR99","doi-asserted-by":"crossref","unstructured":"Kousathanas A, Pairo-Castineira E, Rawlik K, Stuckey A, Odhams CA, Walker S et al (2022) Whole genome sequencing reveals host factors underlying critical Covid-19. Nature 1\u201310","DOI":"10.1038\/s41586-022-04576-6"},{"issue":"11","key":"1261_CR100","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/gerona\/glaa131","volume":"75","author":"CL Kuo","year":"2020","unstructured":"Kuo CL, Pilling LC, Atkins JL et al (2020) APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort. J Gerontol A Biol Sci Med Sci 75(11):2231\u20132232","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"1261_CR101","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1128\/JVI.74.3.1393-1406.2000","volume":"74","author":"Lili Kuo","year":"2000","unstructured":"Kuo L, Godeke GJ, Raamsman MJ et al (2000) Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol 74(3):1393\u20131406","journal-title":"Journal of Virology"},{"key":"1261_CR102","doi-asserted-by":"crossref","unstructured":"Latini A, Agolini E, Novelli A, Borgiani P, Giannini R, Gravina P et al (2020) COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells. Genes 11(9):1010","DOI":"10.3390\/genes11091010"},{"issue":"6","key":"1261_CR103","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jama.2020.27124","volume":"325","author":"AS Lauring","year":"2021","unstructured":"Lauring AS, Hodcroft EB (2021) Genetic variants of SARS-CoV-2\u2014what do they mean? JAMA 325(6):529\u2013531","journal-title":"JAMA"},{"issue":"1","key":"1261_CR104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13613-020-00796-z","volume":"11","author":"JR Lavillegrand","year":"2021","unstructured":"Lavillegrand JR, Garnier M, Spaeth A et al (2021) Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients. Ann Intensive Care 11(1):1\u201310","journal-title":"Ann Intensive Care"},{"key":"1261_CR105","doi-asserted-by":"crossref","unstructured":"Lee HJ (2021) An interactome landscape of SARS-CoV-2 virus-human protein-protein interactions by protein sequence-based multi-label classifiers. bioRxiv","DOI":"10.1101\/2021.11.07.467640"},{"key":"1261_CR106","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.meegid.2018.01.012","volume":"58","author":"S Leopardi","year":"2018","unstructured":"Leopardi S, Holmes EC, Gastaldelli M et al (2018) Interplay between co-divergence and cross-species transmission in the evolutionary history of bat coronaviruses. Infect Genet Evol 58:279\u2013289","journal-title":"Infect Genet Evol"},{"key":"1261_CR107","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","volume":"3","author":"F Li","year":"2016","unstructured":"Li F (2016) Structure function and evolution of coronavirus spike proteins. Annu Rev Virol 3:237\u2013261","journal-title":"Annu Rev Virol"},{"issue":"2","key":"1261_CR108","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Geng M, Peng Y et al (2020a) Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 10(2):102\u2013108","journal-title":"J Pharm Anal"},{"key":"1261_CR109","doi-asserted-by":"crossref","unstructured":"Li Q, Cao Z, Rahman P (2020b) Genetic variability of human angiotensin\u2010converting enzyme 2 (hACE2) among various ethnic populations. Mol Genet Genomic Med 8(8):e1344","DOI":"10.1002\/mgg3.1344"},{"issue":"1","key":"1261_CR110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"B Li","year":"2020","unstructured":"Li B, Clohisey SM, Chia BS et al (2020c) Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection. Nat Commun 11(1):1\u201318","journal-title":"Nat Commun"},{"issue":"1","key":"1261_CR111","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jobb.2021.06.002","volume":"3","author":"Z Li","year":"2021","unstructured":"Li Z, Jiang J, Ruan X, Tong Y, Xu S, Han L, Jianguo XuJ (2021) The zoonotic and natural foci characteristics of SARS-CoV-2. Journal of Biosafety and Biosecurity 3(1):51\u201355","journal-title":"Journal of Biosafety and Biosecurity"},{"issue":"9","key":"1261_CR112","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1745-7270.2005.00082.x","volume":"37","author":"QJ Liao","year":"2005","unstructured":"Liao QJ, Ye LB, Timani KA et al (2005) Activation of NF-\u03baB by the full-length nucleocapsid protein of the SARS coronavirus. Acta Biochim Biophys Sin 37(9):607\u2013612","journal-title":"Acta Biochim Biophys Sin"},{"key":"1261_CR113","doi-asserted-by":"crossref","unstructured":"Liu J, Li S, Liu J et al (2020) Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 55:102763","DOI":"10.1016\/j.ebiom.2020.102763"},{"key":"1261_CR114","doi-asserted-by":"publisher","first-page":"e01410","DOI":"10.1128\/JVI.01410-20","volume":"94","author":"KG Lokugamage","year":"2020","unstructured":"Lokugamage KG, Hage A, Schindewolf C et al (2020) Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV. J Virol 94:e01410-e1420","journal-title":"J Virol"},{"issue":"6","key":"1261_CR115","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M et al (2013) The genotype-tissue expression (GTEx) project. Nat Genet 45(6):580\u2013585","journal-title":"Nat Genet"},{"key":"1261_CR116","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2108891","volume":"385","author":"J Lopez Bernal","year":"2021","unstructured":"Lopez Bernal J, Andrews N, Gower C et al (2021) Effectiveness of Covid-19 vaccines against the B 1617 2 (Delta) variant. N Engl J Med 385:585\u2013594","journal-title":"N Engl J Med"},{"issue":"3","key":"1261_CR117","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ajhg.2020.08.007","volume":"107","author":"M LoPresti","year":"2020","unstructured":"LoPresti M, Beck DB, Duggal P et al (2020) The role of host genetic factors in coronavirus susceptibility: review of animal and systematic review of human literature. Am J Hum Genet 107(3):381\u2013402","journal-title":"Am J Hum Genet"},{"key":"1261_CR118","doi-asserted-by":"publisher","unstructured":"Luo CH, Morris CP, Sachithanandham J et al (2021) Infection with the SARS-CoV-2 delta variant is associated with higher infectious virus loads compared to the alpha variant in both unvaccinated and vaccinated individuals. medRxiv.\u00a0https:\/\/doi.org\/10.1101\/2021.08.15.21262077","DOI":"10.1101\/2021.08.15.21262077"},{"issue":"10127","key":"1261_CR119","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Luliano","year":"2018","unstructured":"Luliano AD, Roguski KM, Chang HH et al (2018) Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391(10127):1285\u20131300","journal-title":"Lancet"},{"key":"1261_CR120","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.01.20144592","author":"C Lu","year":"2020","unstructured":"Lu C, Gam R, Pandurangan AP, Gough J (2020) Genetic risk factors for death with SARS-CoV-2 from the UK Biobank. MedRxiv. https:\/\/doi.org\/10.1101\/2020.07.01.20144592","journal-title":"MedRxiv"},{"key":"1261_CR121","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","volume":"104","author":"WH Mahallawi","year":"2018","unstructured":"Mahallawi WH, Khabour OF, Zhang Q et al (2018) MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine 104:8\u201313","journal-title":"Cytokine"},{"key":"1261_CR122","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1473-3099(20)30985-3","volume":"21","author":"M Marks","year":"2021","unstructured":"Marks M, Millat-Martinez P, Ouchi D et al (2021) Transmission of COVID-19 in 282 clusters in Catalonia Spain: a cohort study. Lancet Infect Dis 21:629\u2013636","journal-title":"Lancet Infect Dis"},{"key":"1261_CR123","unstructured":"McIntosh K, Hirsch MS, Bloom A (2022) Coronavirus disease 2019 (COVID-19): Epidemiology, virology, and prevention. Lancet Infect Dis 1:2019\u201320. https:\/\/www.uptodate.com\/contents\/covid-19-epidemiology-virology-and-prevention.\u00a0Accessed 26 Feb\u00a02022"},{"key":"1261_CR124","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.08.926006","author":"T Meng","year":"2020","unstructured":"Meng T, Cao H, Zhang H et al (2020) The insert sequence in SARS-CoV-2 enhances spike protein cleavage by TMPRSS. BioRxiv. https:\/\/doi.org\/10.1101\/2020.02.08.926006","journal-title":"BioRxiv"},{"issue":"6","key":"1261_CR125","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20(6):355\u2013362","journal-title":"Nat Rev Immunol"},{"key":"1261_CR126","doi-asserted-by":"publisher","first-page":"15214","DOI":"10.1073\/pnas.1407087111","volume":"111","author":"JK Millet","year":"2014","unstructured":"Millet JK, Whittaker GR (2014) Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci U S A 111:15214\u201315219","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1261_CR127","first-page":"159","volume":"45","author":"A Minarowska","year":"2007","unstructured":"Minarowska A, Minarowski L, Karwowska A, Gacko M (2007) Regulatory role of cathepsin D in apoptosis. Folia Histochem Cytobiol 45(3):159\u2013163","journal-title":"Folia Histochem Cytobiol"},{"key":"1261_CR128","doi-asserted-by":"crossref","unstructured":"Moon CY, Schilder, BM, Raj T, Huang KL (2021) Phenome-wide and expression quantitative trait locus associations of coronavirus disease 2019 genetic risk loci. Iscience 24(6):102550","DOI":"10.1016\/j.isci.2021.102550"},{"issue":"1620","key":"1261_CR129","doi-asserted-by":"publisher","first-page":"20120362","DOI":"10.1098\/rstb.2012.0362","volume":"368","author":"AC Nica","year":"2013","unstructured":"Nica AC, Dermitzakis ET (2013) Expression quantitative trait loci: present and future. Philos Trans R Soc Lond B Biol Sci 368(1620):20120362","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"4","key":"1261_CR130","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s11357-020-00217-w","volume":"42","author":"F Nicoli","year":"2020","unstructured":"Nicoli F, Solis-Soto MT, Paudel D et al (2020) Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity. Geroscience 42(4):1015\u20131019","journal-title":"Geroscience"},{"issue":"13","key":"1261_CR131","doi-asserted-by":"publisher","first-page":"e00510","DOI":"10.1128\/JVI.00510-20","volume":"94","author":"A Nguyen","year":"2020","unstructured":"Nguyen A, David JK, Maden SK et al (2020) Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2. J Virol 94(13):e00510-e520","journal-title":"J Virol"},{"issue":"4","key":"1261_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-03513-1","volume":"12","author":"G Novelli","year":"2021","unstructured":"Novelli G, Liu J, Biancolella M, Alonzi T, Novelli A, Patten JJ et al (2021) Inhibition of HECT E3 ligases as potential therapy for COVID-19. Cell Death Dis 12(4):1\u201318","journal-title":"Cell Death Dis"},{"key":"1261_CR133","unstructured":"NSW (2021) Government. Living Evidence - SARS-CoV-2 variants. [WWW Document].\u00a0https:\/\/aci.health.nsw.gov.au\/covid-19\/critical-intelligence-unit\/sars-cov-2-variants. Accessed 24 Jun\u00a02021"},{"issue":"1","key":"1261_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43042-020-00122-z","volume":"21","author":"BO Oladejo","year":"2020","unstructured":"Oladejo BO, Adeboboye CF, Adebolu TT (2020) Understanding the genetic determinant of severity in viral diseases: a case of SARS-Cov-2 infection. Egypt J Med Hum Genet 21(1):1\u201311","journal-title":"Egypt J Med Hum Genet"},{"key":"1261_CR135","doi-asserted-by":"crossref","unstructured":"Ortiz-Prado E, Simba\u00f1a-Rivera K, G\u00f3mez-Barreno L et al (2020) Clinical, molecular and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis 98(1):115094","DOI":"10.1016\/j.diagmicrobio.2020.115094"},{"key":"1261_CR136","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S2213-2600(21)00218-6","volume":"9","author":"MF Osuchowski","year":"2021","unstructured":"Osuchowski MF, Winkler MS, Skirecki T et al (2021) The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Resp Med 9:622\u2013642","journal-title":"Lancet Resp Med"},{"issue":"1","key":"1261_CR137","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/imr.12897","volume":"296","author":"IG Ovsyannikova","year":"2020","unstructured":"Ovsyannikova IG, Haralambieva IH, Crooke SN et al (2020) The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Immunol Rev 296(1):205\u2013219","journal-title":"Immunol Rev"},{"issue":"7848","key":"1261_CR138","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","volume":"591","author":"E Pairo-Castineira","year":"2021","unstructured":"Pairo-Castineira E, Clohisey S, Klaric L et al (2021) Genetic mechanisms of critical illness in Covid-19. Nature 591(7848):92\u201398","journal-title":"Nature"},{"key":"1261_CR139","doi-asserted-by":"crossref","unstructured":"Pan D, Sze S, Minhas JS et al (2020) The impact of ethnicity on clinical outcomes in COVID-19: a systematic review. E Clin Med 23:100404","DOI":"10.1016\/j.eclinm.2020.100404"},{"issue":"4","key":"1261_CR140","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3345\/cep.2020.00493","volume":"63","author":"SE Park","year":"2020","unstructured":"Park SE (2020) Epidemiology, virology, and clinical features of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clin Exp Pediatr 63(4):119","journal-title":"Clin Exp Pediatr"},{"key":"1261_CR141","doi-asserted-by":"publisher","first-page":"22303","DOI":"10.1038\/s41598-020-79033-3","volume":"10","author":"N Parkinson","year":"2020","unstructured":"Parkinson N, Rodgers N, Fourman MH et al (2020) Systematic review and meta-analysis identifies potential host therapeutic targets in COVID-19. Sci Rep 10:22303","journal-title":"Sci Rep"},{"issue":"1","key":"1261_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-19741-6","volume":"11","author":"H Peckham","year":"2020","unstructured":"Peckham H, de Gruijter NM, Raine C et al (2020) Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun 11(1):1\u201310","journal-title":"Nat Commun"},{"issue":"11","key":"1261_CR143","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng Y, Mentzer AJ, Liu G et al (2020) Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat Immunol 21(11):1336\u20131345","journal-title":"Nat Immunol"},{"key":"1261_CR144","doi-asserted-by":"crossref","unstructured":"Phan MV, Ngo Tri T, Hong Anh P et al (2018) Identification and characterization of Coronaviridae genomes from Vietnamese bats and rats based on conserved protein domains. Virus Evol 4(2) vey035","DOI":"10.1093\/ve\/vey035"},{"issue":"5","key":"1261_CR145","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC (2005) Mechanisms of type-I-and type-II-interferon-mediated signaling. Nat Rev Immunol 5(5):375\u2013386","journal-title":"Nat Rev Immunol"},{"key":"1261_CR146","doi-asserted-by":"crossref","unstructured":"Pujadas E, Chaudhry F, McBride R et al (2020) SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Resp Med 8(9):e70","DOI":"10.1016\/S2213-2600(20)30354-4"},{"issue":"15","key":"1261_CR147","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin C, Zhou L, Hu Z et al (2020) Dysregulation of immune response in patients with COVID-19 in Wuhan. China Clin Infect Dis 71(15):762\u2013768","journal-title":"China Clin Infect Dis"},{"issue":"5","key":"1261_CR148","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1073\/pnas.0908044107","volume":"107","author":"A Rausell","year":"2010","unstructured":"Rausell A, Juan D, Pazos F, Valencia A (2010) Protein interactions and ligand binding: from protein subfamilies to functional specificity. Proc Natl Acad Sci U S A 107(5):1995\u20132000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1261_CR149","first-page":"22","volume":"1","author":"U Repnik","year":"1824","unstructured":"Repnik U, Stoka V, Turk V (1824) Turk B (2012) Lysosomes and lysosomal cathepsins in cell death. Biochim Biophys Acta Proteins Proteom 1:22\u201333","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"issue":"6","key":"1261_CR150","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3390\/genes12060881","volume":"12","author":"R Russo","year":"2021","unstructured":"Russo R, Andolfo I, Lasorsa VA, Cantalupo S, Marra R, Frisso G et al (2021) The TNFRSF13C H159Y variant is associated with severe COVID-19: a retrospective study of 500 patients from Southern Italy. Genes 12(6):881","journal-title":"Genes"},{"issue":"7","key":"1261_CR151","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri2314","volume":"8","author":"AJ Sadler","year":"2008","unstructured":"Sadler AJ, Williams BR (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8(7):559\u2013568","journal-title":"Nat Rev Immunol"},{"key":"1261_CR152","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Wilson SJ, Panis M et al (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481\u2013485","journal-title":"Nature"},{"issue":"1","key":"1261_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40001-021-00516-8","volume":"26","author":"S SeyedAlinaghi","year":"2021","unstructured":"SeyedAlinaghi S, Mehrtak M, MohsseniPour M, Mirzapour P, Barzegary A, Habibi P et al (2021) Genetic susceptibility of COVID-19: a systematic review of current evidence. Eur J Med Res 26(1):1\u201312","journal-title":"Eur J Med Res"},{"issue":"7807","key":"1261_CR154","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang J, Ye G, Shi K et al (2020a) Structural basis of receptor recognition by SARS-CoV-2. Nature 581(7807):221\u2013224","journal-title":"Nature"},{"key":"1261_CR155","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang J, Wan Y, Luo C et al (2020b) Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A 117:11727\u201311734","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1261_CR156","doi-asserted-by":"publisher","first-page":"132","DOI":"10.5492\/wjccm.v10.i4.132","volume":"10","author":"S Shenoy","year":"2021","unstructured":"Shenoy S (2021) SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: A systematic review. World J Crit Care Med 10(4):132","journal-title":"World J Crit Care Med"},{"key":"1261_CR157","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.1073\/pnas.0505577102","volume":"102","author":"G Simmons","year":"2005","unstructured":"Simmons G, Gosalia DN, Rennekamp AJ et al (2005) Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A 102:11876\u201311881","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1261_CR158","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng1706","volume":"38","author":"AD Skol","year":"2006","unstructured":"Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38(2):209\u2013213","journal-title":"Nat Genet"},{"issue":"1","key":"1261_CR159","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine T, Perez-Potti A, Rivera-Ballesteros O et al (2020) Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183(1):158\u2013168","journal-title":"Cell"},{"issue":"1","key":"1261_CR160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-022-07034-w","volume":"22","author":"S Suh","year":"2022","unstructured":"Suh S, Lee S, Gym H, Yoon S, Park S, Cha J et al (2022) A systematic review on papers that study on Single Nucleotide Polymorphism that affects coronavirus 2019 severity. BMC Infect Dis 22(1):1\u201311","journal-title":"BMC Infect Dis"},{"key":"1261_CR161","unstructured":"Stop TB Partnership (2020) The potential impact of the covid-19 response on tuberculosis in high-burden countries, a modelling analysis. https:\/\/www.stoptb.org\/assets\/documents\/news\/Modeling%20Report_1%20May%202020_FINAL.pdf"},{"issue":"3","key":"1261_CR162","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cell.2020.06.010","volume":"182","author":"J Sun","year":"2020","unstructured":"Sun J, Zhuang Z, Zheng J et al (2020) Generation of a broadly useful model for COVID-19 pathogenesis vaccination and treatment. Cell 182(3):734\u2013743","journal-title":"Cell"},{"key":"1261_CR163","doi-asserted-by":"crossref","unstructured":"Suri JS, Agarwal S, Gupta SK et al (2021) A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence. Comput Biol Med 130:104210","DOI":"10.1016\/j.compbiomed.2021.104210"},{"issue":"1","key":"1261_CR164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41231-019-0050-7","volume":"4","author":"AA Seyhan","year":"2019","unstructured":"Seyhan AA (2019) Lost in translation: the valley of death across preclinical and clinical divide\u2013identification of problems and overcoming obstacles. Transl Med Commun 4(1):1\u201319","journal-title":"Transl Med Commun"},{"issue":"1","key":"1261_CR165","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cell.2020.12.006","volume":"184","author":"WM Schneider","year":"2021","unstructured":"Schneider WM, Luna JM, Hoffmann HH et al (2021) Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks. Cell 184(1):120\u2013132","journal-title":"Cell"},{"issue":"10","key":"1261_CR166","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00018-010-0287-9","volume":"67","author":"K Schrader","year":"2010","unstructured":"Schrader K, Huai J, J\u00f6ckel L et al (2010) Non-caspase proteases: triggers or amplifiers of apoptosis? Cell Mol Life Sci 67(10):1607\u20131618","journal-title":"Cell Mol Life Sci"},{"key":"1261_CR167","doi-asserted-by":"crossref","unstructured":"Stoeger T, Amaral LAN (2020) Meta-Research: COVID-19 research risks ignoring important host genes due to pre-established research patterns. Elife 9:e61981","DOI":"10.7554\/eLife.61981"},{"key":"1261_CR168","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s42003-021-02030-3","volume":"4","author":"K Suryamohan","year":"2021","unstructured":"Suryamohan K, Diwanji D, Stawiski EW et al (2021) Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2. Commun Biol 4:475","journal-title":"Commun Biol"},{"issue":"4","key":"1261_CR169","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nsmb0404-293","volume":"11","author":"RC Stevens","year":"2004","unstructured":"Stevens RC (2004) Long live structural biology. Nat Struct Mol Biol 11(4):293\u2013295","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"1261_CR170","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV et al (2019) The molecular machinery of regulated cell death. Cell Res 29(5):347\u2013364","journal-title":"Cell Res"},{"key":"1261_CR171","doi-asserted-by":"crossref","unstructured":"Tang D, Comish P, Kang R (2020) The hallmarks of COVID-19 disease. PLoS Pathog 16(5):e1008536","DOI":"10.1371\/journal.ppat.1008536"},{"issue":"2","key":"1261_CR172","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/jmv.26319","volume":"93","author":"L Torre-Fuentes","year":"2021","unstructured":"Torre-Fuentes L, Mat\u00edas-Guiu J, Hern\u00e1ndez-Lorenzo L, Montero-Escribano P, Pytel V, Porta-Etessam J et al (2021) ACE2 TMPRSS2 and Furin variants and SARS-CoV-2 infection in Madrid Spain. J Med Virol 93(2):863\u2013869","journal-title":"J Med Virol"},{"key":"1261_CR173","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.virol.2019.04.009","volume":"535","author":"JM Trigueiro-Louro","year":"2019","unstructured":"Trigueiro-Louro JM, Correia V, Santos LA et al (2019) To hit or not to hit: large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential. Virology 535:297\u2013307","journal-title":"Virology"},{"key":"1261_CR174","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.csbj.2020.07.017","volume":"18","author":"J Trigueiro-Louro","year":"2020","unstructured":"Trigueiro-Louro J, Correia V, Figueiredo-Nunes I et al (2020) Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike. Comput Struct Biotechnol J 18:2117\u20132131","journal-title":"Comput Struct Biotechnol J"},{"issue":"6","key":"1261_CR175","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","volume":"52","author":"N Vabret","year":"2020","unstructured":"Vabret N, Britton GJ, Gruber C et al (2020) Immunology of COVID-19: current state of the science. Immunity 52(6):910\u2013941","journal-title":"Immunity"},{"issue":"7","key":"1261_CR176","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/jama.2020.13719","volume":"324","author":"CI Van Der Made","year":"2020","unstructured":"Van Der Made CI, Simons A, Schuurs-Hoeijmakers J et al (2020) Presence of genetic variants among young men with severe COVID-19. JAMA 324(7):663\u2013673","journal-title":"JAMA"},{"issue":"3","key":"1261_CR177","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jinf.2020.06.067","volume":"81","author":"KA Walsh","year":"2020","unstructured":"Walsh KA, Jordan K, Clyne B et al (2020) SARS-CoV-2 detection, viral load and infectivity over the course of an infection: SARS-CoV-2 detection, viral load and infectivity. J Infect 81(3):357\u2013371","journal-title":"J Infect"},{"issue":"2","key":"1261_CR178","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA et al (2020) Structure function and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181(2):281\u2013292","journal-title":"Cell"},{"issue":"6","key":"1261_CR179","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ajem.2007.10.031","volume":"26","author":"H Wang","year":"2008","unstructured":"Wang H, Ma S (2008) The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 26(6):711\u2013715","journal-title":"Am J Emerg Med"},{"issue":"1","key":"1261_CR180","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cell.2020.12.004","volume":"184","author":"R Wang","year":"2021","unstructured":"Wang R, Simoneau CR, Kulsuptrakul J et al (2021) Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses. Cell 184(1):106\u2013119","journal-title":"Cell"},{"key":"1261_CR181","doi-asserted-by":"crossref","unstructured":"Weiner 3rd J, Suwalski P, Holtgrewe M, Rakitko A, Thibeault C, M\u00fcller M, Heidecker B (2021) Increased risk of severe clinical course of COVID-19 in carriers of HLA-C* 04: 01. EClinicalMedicine 40:101099","DOI":"10.1016\/j.eclinm.2021.101099"},{"issue":"1","key":"1261_CR182","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cell.2020.10.028","volume":"184","author":"J Wei","year":"2021","unstructured":"Wei J, Alfajaro MM, DeWeirdt PC et al (2021) Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection. Cell 184(1):76\u201391","journal-title":"Cell"},{"key":"1261_CR183","doi-asserted-by":"crossref","unstructured":"Weiskopf D, Schmitz KS, Raadsen MP et al (2020) Phenotype and kinetics of SARS-CoV-2\u2013specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol 5(48):eabd2071","DOI":"10.1126\/sciimmunol.abd2071"},{"issue":"1","key":"1261_CR184","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","volume":"136","author":"CK Wong","year":"2004","unstructured":"Wong CK, Lam CWK, Wu AKL et al (2004) Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136(1):95\u2013103","journal-title":"Clin Exp Immunol"},{"key":"1261_CR185","unstructured":"World Health Organization (2006) SARS: how a global epidemic was stopped. Manila: WHO Regional Office for the Western Pacific. https:\/\/www.file:\/\/\/D:\/DS\/suzana.david\/Downloads\/9290612134_eng%20(1).pdf"},{"key":"1261_CR186","unstructured":"World Health Organization, WHO March 11 (2020) WHO Director-General's opening remarks at the media briefing on COVID-19\u201411 March 2020. https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020.\u00a0Accessed 20 Dec\u00a02021. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/transcripts\/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf"},{"key":"1261_CR187","unstructured":"World Health organization, WHO November 17 (2020) Weekly epidemiological update - 17 November 2020. https:\/\/www.file:\/\/\/D:\/DS\/suzana.david\/Downloads\/weekly-epi-update-14.pdf"},{"key":"1261_CR188","unstructured":"World Health Organization, WHO January 20 (2021) SARS-CoV-2 in animals used for fur farming: GLEWS+ risk assessment 20 January 2021 (No WHO\/2019-nCoV\/fur_farming\/risk_assessment\/20211). World Health Organization. http:\/\/www.fao.org\/3\/cb3368en\/cb3368en.pdf"},{"key":"1261_CR189","unstructured":"World Health Organization, WHO (2022) Tracking SARS-CoV-2 variants. https:\/\/www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants\/.\u00a0Accessed 26 Feb\u00a02022"},{"key":"1261_CR190","unstructured":"World Health Organization, WHO (2020) The potential impact of health service disruptions on the burden of malaria, a modelling analysis for countries in sub-Saharan Africa. https:\/\/www.apps.who.int\/iris\/bitstream\/handle\/10665\/331845\/9789240004641-eng.pdf"},{"issue":"7798","key":"1261_CR191","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B et al (2020a) A new coronavirus associated with human respiratory disease in China. Nature 579(7798):265\u2013269","journal-title":"Nature"},{"key":"1261_CR192","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3389\/fmicb.2020.01576","volume":"11","author":"J Wu","year":"2020","unstructured":"Wu J, Yuan X, Wang B et al (2020b) Severe acute respiratory syndrome coronavirus 2: from gene structure to pathogenic mechanisms and potential therapy. Front Microbiol 11:1576","journal-title":"Front Microbiol"},{"issue":"4","key":"1261_CR193","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y et al (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Resp Med 8(4):420\u2013422","journal-title":"Lancet Resp Med"},{"issue":"1","key":"1261_CR194","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1600-065X.2008.00727.x","volume":"227","author":"M Yoneyama","year":"2009","unstructured":"Yoneyama M, Fujita T (2009) RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 227(1):54\u201365","journal-title":"Immunol Rev"},{"issue":"11","key":"1261_CR195","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/infdis\/jiaa077","volume":"221","author":"P Yu","year":"2020","unstructured":"Yu P, Zhu J, Zhang Z, Han Y (2020) A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. J Infect Dis 221(11):1757\u20131761","journal-title":"J Infect Dis"},{"issue":"18","key":"1261_CR196","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.1128\/JVI.01049-10","volume":"84","author":"J Zhao","year":"2010","unstructured":"Zhao J, Zhao J, Perlman S (2010) T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. J Virol 84(18):9318\u20139325","journal-title":"J Virol"},{"issue":"6","key":"1261_CR197","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","volume":"44","author":"J Zhao","year":"2016","unstructured":"Zhao J, Zhao J, Mangalam AK et al (2016) Airway memory CD4+ T cells mediate protective immunity against emerging respiratory coronaviruses. Immunity 44(6):1379\u20131391","journal-title":"Immunity"},{"issue":"2","key":"1261_CR198","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/cid\/ciaa1150","volume":"73","author":"J Zhao","year":"2021","unstructured":"Zhao J, Yang Y, Huang H et al (2021) Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clin Infect Dis 73(2):328\u2013331","journal-title":"Clin Infect Dis"},{"key":"1261_CR199","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2355-0","volume":"583","author":"X Zhang","year":"2020","unstructured":"Zhang X, Tan Y, Ling Y et al (2020a) Viral and host factors related to the clinical outcome of COVID-19. Nature 583:437\u2013440","journal-title":"Nature"},{"key":"1261_CR200","unstructured":"Zhang Q, Bastard P, Liu Z et al (2020b) Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370(6515):eabd4570"},{"issue":"1","key":"1261_CR201","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/infdis\/jiaa224","volume":"222","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Qin L, Zhao Y, Zhang P, Xu B, Li K et al (2020c) Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019. J Infect Dis 222(1):34\u201337","journal-title":"J Infect Dis"},{"issue":"5","key":"1261_CR202","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","volume":"17","author":"M Zheng","year":"2020","unstructured":"Zheng M, Gao Y, Wang G et al (2020b) Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol 17(5):533\u2013535","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"1261_CR203","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","volume":"17","author":"HY Zheng","year":"2020","unstructured":"Zheng HY, Zhang M, Yang CX et al (2020a) Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol 17(5):541\u2013543","journal-title":"Cell Mol Immunol"},{"issue":"7798","key":"1261_CR204","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273","journal-title":"Nature"},{"key":"1261_CR205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-021-00644-x","volume":"6","author":"W Zhou","year":"2021","unstructured":"Zhou W, Wang W (2021) Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines. Signal Transduct Target Ther 6:1\u20136","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1261_CR206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20314-w","volume":"12","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Feng F, Hu G et al (2021) A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry. Nat Commun 12(1):1\u201311","journal-title":"Nat Commun"},{"issue":"10","key":"1261_CR207","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1038\/nprot.2007.366","volume":"2","author":"KT Zondervan","year":"2007","unstructured":"Zondervan KT, Cardon LR (2007) Designing candidate gene and genome-wide case\u2013control association studies. Nat Protoc 2(10):2492\u20132501","journal-title":"Nat Protoc"},{"issue":"2","key":"1261_CR208","doi-asserted-by":"publisher","first-page":"25","DOI":"10.33602\/mebm.3.2.3","volume":"3","author":"R Zunec","year":"2020","unstructured":"Zunec R (2020) A review of HLA and COVID-19 association studies. Mol Exp Biol Med 3(2):25\u201330","journal-title":"Mol Exp Biol Med"}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-022-01261-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00251-022-01261-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-022-01261-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T09:04:00Z","timestamp":1668243840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00251-022-01261-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":208,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1261"],"URL":"https:\/\/doi.org\/10.1007\/s00251-022-01261-w","relation":{},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"value":"0093-7711","type":"print"},{"value":"1432-1211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,29]]},"assertion":[{"value":"10 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}